NCT07181941
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
Neoplasms, Plasma Cell
Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.
2,639 public trials
556 recruiting studies
Neoplasms, Plasma Cell trial results
Recruiting
ELISA in Relapsed/Refractory MM
NCT06832865
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +18 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT05283993
- Conditions
- Abnormalities, Multiple, Amyloidosis, Blood Protein Disorders, +44 more
- Locations
-
- Peking University First Hospital Beijing, China
NCT00900198
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +18 more
- Locations
-
- UC Davis Sacramento, California, United States
- University of Colorado, Denver Aurora, Colorado, United States
- Emory University Atlanta, Georgia, United States
- Indiana University - Purdue Indianapolis, Indiana, United States
NCT06182774
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Cross Cancer Institute Edmonton, Alberta, Canada
- BCCA - Kelowna Kelowna, British Columbia, Canada
- BCCA - Vancouver Vancouver, British Columbia, Canada
- CancerCare Manitoba Winnipeg, Manitoba, Canada
NCT07620275
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Biotherapeutic Department of Chinese PLA General Hospital Beijing, Beijing Municipality, China
- Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University Beijing, China
- National Clinical Research Center for Blood Diseases, State Key Laboratory of Experimental Hematology, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College Tianjin, China
Recruiting
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
NCT06976476
- Conditions
- Agammaglobulinemia, Blood Protein Disorders, Cardiovascular Diseases, +18 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk-Commack (All Protocol Activity) Commack, New York, United States
NCT04314752
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
NCT06953960
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of Southern California /ID# 272414 Los Angeles, California, United States
- Dana-Farber Cancer Institute /ID# 271846 Boston, Massachusetts, United States
- University of Michigan Health System - Ann Arbor /ID# 271536 Ann Arbor, Michigan, United States
- Memorial Sloan Kettering Cancer Center - New York - York Avenue /ID# 271214 New York, United States